Literature DB >> 30810903

Participants' Lived Experience with the Illness Management and Recovery (IMR) Program in Relation to their Recovery-Process.

Sofie B Jensen1, Lene F Eplov2, Iben Gammelgaard3, Kim T Mueser4, Kirsten S Petersen5.   

Abstract

The Illness Management and Recovery program (IMR) is developed to support people with severe mental illnesses in their recovery-process. The theory behind the program highlight the importance of helping people develop tailored illness management skills which will help achieve personal and clinical recovery. However, little is known about participants' experience with IMR in relation to their recoveryprocess. The aim of the present study is to describe the participants' lived experience with IMR, explore whether they experienced changes, and examine how these changes related to their recovery during or after their participation in IMR. A Qualitative study. The participants' experience with the IMR program in relation to their recovery unveiled three main themes; "Social connection with other IMR-group members', 'In IMR, we talked about our everyday lives with mental illness' and 'In IMR we learned about recovery as a personal experience'.

Entities:  

Keywords:  Clinical and personal recovery; Hope; IMR; Illness management and recovery; Lived experience; Severe mental illness

Year:  2019        PMID: 30810903     DOI: 10.1007/s10597-019-00383-y

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  16 in total

1.  A randomized controlled trial of the illness management and recovery program for persons with schizophrenia.

Authors:  Rickard Färdig; Tommy Lewander; Lennart Melin; Fredrik Folke; Anders Fredriksson
Journal:  Psychiatr Serv       Date:  2011-06       Impact factor: 3.084

2.  Research on evidence-based practices: future directions in an era of recovery.

Authors:  William Anthony; E Sally Rogers; Marianne Farkas
Journal:  Community Ment Health J       Date:  2003-04

3.  HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI.

Authors:  P P RICKHAM
Journal:  Br Med J       Date:  1964-07-18

4.  Integrating assertive community treatment and illness management and recovery for consumers with severe mental illness.

Authors:  Michelle P Salyers; Alan B McGuire; Angela L Rollins; Gary R Bond; Kim T Mueser; Veronica R Macy
Journal:  Community Ment Health J       Date:  2010-01-14

5.  Should psychosocial treatment for schizophrenia focus on the proximal or distal consequences of the disorder?

Authors:  Kim T Mueser
Journal:  J Ment Health       Date:  2012-12

6.  The Illness Management and Recovery program: rationale, development, and preliminary findings.

Authors:  Kim T Mueser; Piper S Meyer; David L Penn; Richard Clancy; Donna M Clancy; Michelle P Salyers
Journal:  Schizophr Bull       Date:  2006-08-09       Impact factor: 9.306

Review 7.  Remission in schizophrenia: proposed criteria and rationale for consensus.

Authors:  Nancy C Andreasen; William T Carpenter; John M Kane; Robert A Lasser; Stephen R Marder; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

8.  A one year follow-up of illness management and recovery: participants' accounts of its impact and uniqueness.

Authors:  David Roe; Ilanit Hasson-Ohayon; Michelle P Salyers; Shlomo Kravetz
Journal:  Psychiatr Rehabil J       Date:  2009

9.  A randomized controlled trial of the effectiveness of the illness management and recovery program.

Authors:  Ilanit Hasson-Ohayon; David Roe; Shlomo Kravetz
Journal:  Psychiatr Serv       Date:  2007-11       Impact factor: 3.084

Review 10.  Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis.

Authors:  Mary Leamy; Victoria Bird; Clair Le Boutillier; Julie Williams; Mike Slade
Journal:  Br J Psychiatry       Date:  2011-12       Impact factor: 9.319

View more
  1 in total

1.  Meaningful Activities and Recovery (MA&R): the effect of a novel rehabilitation intervention among persons with psychiatric disabilities on activity engagement-study protocol for a randomized controlled trial.

Authors:  Siv Therese Bogevik Bjørkedal; Ulrika Bejerholm; Lene Falgaard Eplov; Tom Møller
Journal:  Trials       Date:  2020-09-14       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.